People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear. People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear. Deaths (Fatalities), Coronavirus (2019-nCoV), Disease Rates, Semaglutide (Drug), Heart, Weight, Clinical Trials, Research, Drugs (Pharmaceuticals), Journal of the American College of Cardiology NYT > Science